ReviewHeliyon2024

A prospective, single-centre study of the feasibility of the use of augmented reality for improving the safety and traceability of injectable investigational cancer drug compounding.

Arthur Lecoutre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.